InsightfulValue
← Home

Royalty Pharma
Royalty Pharma

Pharma / Pharmaceutical royalties and drug financing


πŸ”§ Tools

βœ… Due Diligence
🧩 Revenue Segmentation by Product

Switch to Location
Fiscal year Segment Value
2025 Financial Royalty Assets 2.26B
2025 Royalty Income, Other 117.04M
2024 Financial Royalty Assets 2.15B
2024 Royalty Income, Other 114.15M
2023 Financial Royalty Assets 2.2B
2023 Royalty Income, Other 155.97M
2023 Intangible Royalty Assets 835K
2022 Financial Royalty Assets 2.13B
2022 Royalty Income, Other 74.64M
Royalty Pharma

πŸ’° Explore more revenue segmentation data for Royalty Pharma!

Sign up for free or log in

πŸ™Œ Join now to get "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" at no cost

© 2024 - 2026 InsightfulValue.com. All rights reserved. Newsletter
Legal